Quarterly Transactions Made in Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE). The information is specifically focused on institutions that hold shares of Sage Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2022 | 2,976,492 | 1,404,739 | 4,381,231 | 2,786,543 | 13,187 | 2,799,730 | 1,581,501 | |
| Q4 2022 | 1,989,976 | 2,026,527 | 4,016,503 | 2,034,272 | 0 | 2,034,272 | 1,982,231 | |
| Q1 2023 | 3,004,667 | 1,576,737 | 4,581,404 | 1,437,169 | 0 | 1,437,169 | 3,144,235 | |
| Q2 2023 | 6,273,344 | 1,163,979 | 7,437,323 | 5,388,153 | 452,022 | 5,840,175 | 1,597,148 | |
| Q3 2023 | 6,060,108 | 7,639,862 | 13,699,970 | 4,432,307 | 490,702 | 4,923,009 | 8,776,961 | |
| Q4 2023 | 4,322,721 | 9,731,441 | 14,054,162 | 5,882,233 | 100 | 5,882,333 | 8,171,829 | |
| Q1 2024 | 7,982,802 | 7,211,977 | 15,194,779 | 3,270,549 | 0 | 3,270,549 | 11,924,230 | |
| Q2 2024 | 8,178,739 | 1,728,437 | 9,907,176 | 14,712,966 | 0 | 14,712,966 | -4,805,790 | |
| Q3 2024 | 5,027,069 | 219,286 | 5,246,355 | 6,810,990 | 0 | 6,810,990 | -1,564,635 | |
| Q4 2024 | 6,111,426 | 2,655,504 | 8,766,930 | 9,339,111 | 1,000 | 9,340,111 | -573,181 | |
| Q1 2025 | 6,787,789 | 16,360,169 | 23,147,958 | 11,050,067 | 0 | 11,050,067 | 12,097,891 | |
| Q2 2025 | 7,698,300 | 7,767,446 | 15,465,746 | 9,891,688 | 0 | 9,891,688 | 5,574,058 | |
| Q3 2025 | — | 0 | 52 | 52 | -52 | |||